| 2000 |
The PX (phox homology) domain of SNX15 is required for its membrane association and for association with the platelet-derived growth factor receptor (PDGFR). SNX15 did not associate with EGF or insulin receptors. |
Overexpression, membrane fractionation, co-immunoprecipitation, domain deletion analysis |
The Journal of biological chemistry |
Medium |
11085978
|
| 2000 |
Overexpression of SNX15 leads to decreased processing of insulin and hepatocyte growth factor receptors to their mature subunits, and causes mislocalization of furin (the endoprotease responsible for cleavage of these receptors), indicating SNX15 disrupts normal trafficking of proteins through the trans-Golgi network or recycling endosomes. |
Overexpression in COS-7 cells, immunofluorescence, receptor processing assays |
The Journal of biological chemistry |
Medium |
11085978
|
| 2000 |
Overexpression of myc-SNX15 in COS-7 cells alters morphology of endosomal compartments (generating enlarged ring and amorphous membrane structures containing proteins from lysosomes, late endosomes, early endosomes, and TGN), severely inhibits endocytosis of transferrin, and slows endocytosis and recycling of tac-TGN38 and tac-furin, establishing SNX15 as a regulator of the endocytic trafficking pathway. |
Transient transfection, immunofluorescence, endocytosis assays (transferrin, tac-TGN38, tac-furin), recycling assays |
Traffic (Copenhagen, Denmark) |
Medium |
11208079
|
| 2013 |
SNX15 associates with early endosomes via its PX domain in a phosphatidylinositol 3-phosphate (PtdIns3P)-dependent manner, and also directly binds clathrin through a non-canonical clathrin-binding box, associating with clathrin-coated pits and vesicles. RNAi-mediated suppression of SNX15 causes a delay in EGF receptor degradation due to a defect in movement of newly internalized EGF-receptor-labeled vesicles into early endosomes. |
RNAi loss-of-function screen, live-cell imaging, co-immunoprecipitation/pulldown, PtdIns3P-binding assays |
Journal of cell science |
High |
23986476
|
| 2013 |
The MIT domain of SNX15a (splice variant) binds phosphoinositides in a Ca2+-dependent manner; the loop between the first and second α-helices of the MIT domain binds a Ca2+ ion and facilitates membrane association. |
In vitro phosphoinositide-binding assay, biochemical Ca2+-binding experiments |
Journal of biochemistry |
Medium |
23423459
|
| 2015 |
SNX15-decorated EGF-receptor-containing endocytic vesicles are distinct from APPL1-containing endosomes (no heterotypic fusion observed by live imaging), but undergo direct fusion with Rab5-positive early endosomes, and co-label with the ESCRT-0 subunit Hrs at peripheral EEA1-negative endosomal intermediates. |
Live-cell fluorescence imaging, co-localization analysis at subpixel resolution, RNA silencing |
Journal of cell science |
Medium |
25588841
|
| 2015 |
SNX15 overexpression increases APP at the cell surface by accelerating APP recycling, whereas SNX15 downregulation reduces cell-surface APP. Neither manipulation affects BACE1 or γ-secretase activity or levels, demonstrating SNX15 specifically regulates APP recycling to reduce Aβ generation. |
Overexpression, siRNA knockdown, cell-surface biotinylation, recycling assay, Aβ ELISA, AAV-mediated expression in transgenic AD mice |
Molecular neurobiology |
Medium |
26115702
|
| 2023 |
IST1 interacts with the MIT domain-containing SNX15 on endosomes. SNX15 and IST1 co-occupy a clathrin-containing subdomain on the endosomal perimeter, and CHMP1B and SNX15 alternately recruit IST1 to this subdomain or to the base of endosomal tubules, linking SNX15 to ESCRT-III-mediated recycling carrier scission. |
Co-immunoprecipitation, live-cell microscopy, kinetic and spatial co-localization analysis |
Traffic (Copenhagen, Denmark) |
Medium |
37577466 37926552
|
| 2022 |
A RARA-SNX15 fusion protein (RARA-SNX15L) formed by chromosomal rearrangement in APL retains the SNX15 PX domain and directly associates with endogenous SNX15 and with itself, as shown by co-immunoprecipitation. |
Co-immunoprecipitation of RARA-SNX15L fusion protein |
International journal of hematology |
Low |
35854096
|